Literature DB >> 6819768

Biological properties of ICRF-159 and related bis(dioxopiperazine) compounds.

E H Herman, D T Witiak, K Hellmann, V S Waravdekar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6819768     DOI: 10.1016/s1054-3589(08)60025-3

Source DB:  PubMed          Journal:  Adv Pharmacol Chemother        ISSN: 0065-3144


× No keyword cloud information.
  21 in total

Review 1.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

Review 2.  Topoisomerases as anticancer targets.

Authors:  Justine L Delgado; Chao-Ming Hsieh; Nei-Li Chan; Hiroshi Hiasa
Journal:  Biochem J       Date:  2018-01-23       Impact factor: 3.857

3.  Metrazol enhances brain penetration and therapeutic efficacy of some anticancer agents: implications for brain metastases.

Authors:  N Greig; D Newell; K Hellmann
Journal:  Clin Exp Metastasis       Date:  1984 Jan-Mar       Impact factor: 5.150

Review 4.  Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer.

Authors:  K Hoekman; W J van der Vijgh; J B Vermorken
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

5.  Therapeutic efficacy of two different cytostatic-linked phosphonates in combination with razoxane in the transplantable osteosarcoma of the rat.

Authors:  T Klenner; F Wingen; B Keppler; P Valenzuela-Paz; F Amelung; D Schmähl
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

6.  Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models.

Authors:  T Narita; S Yaguchi; T Komatsu; M Takase; A Hoshino; M Inaba; S Tsukagoshi
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

7.  Reduction of chronic doxorubicin cardiotoxicity in beagle dogs by bis-morpholinomethyl derivative of razoxane (ICRF-159).

Authors:  E H Herman; V J Ferrans; H B Bhat; D T Witiak
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

8.  Antimetastatic effects of razoxane in a rat osteosarcoma model.

Authors:  F Wingen; H Spring; D Schmähl
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

9.  Effects of rotational stress on the effectiveness of cyclophosphamide and razoxane in mice bearing Lewis lung carcinoma.

Authors:  L Perissin; S Zorzet; P Piccini; V Rapozzi; T Giraldi
Journal:  Clin Exp Metastasis       Date:  1991 Nov-Dec       Impact factor: 5.150

10.  Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane.

Authors:  S L Maloney; D C Sullivan; S Suchting; J M J Herbert; E M Rabai; Z Nagy; J Barker; S Sundar; R Bicknell
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.